Boehringer, Micromet in cancer deal

Boehringer Ingelheim GmbH (Ingelheim, Germany) and Micromet Inc. (NASDAQ:MITI) partnered to develop and commercialize a bispecific T cell engager (BiTE) antibody to treat multiple myeloma (MM). Microm...